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Abstract The CONSTANCES general-purpose cohort is
intended to serve as an epidemiological research infras-
tructure accessible to the epidemiologic research commu-
nity with a focus on occupational and social factors, and on
chronic diseases and aging. CONSTANCES will also
provide useful public health information to the public
health authorities since it was designed as a large repre-
sentative sample of the general French adult population.
CONSTANCES is designed as a randomly selected rep-
resentative sample of French adults aged 18–69 years at
inception; 200,000 subjects will be included over a five-
year period. At inclusion, the selected subjects are invited
to complete questionnaires and to attend a Health Screen-
ing Center (HSC) for a comprehensive health examination.
A biobank will be set up. The follow-up includes a yearly
self-administered questionnaire, and a periodic visit to an
HSC. Social and health data are collected from the French
national databases. Data collected for participants include
social and demographic characteristics, socioeconomic
status, life events, behaviors, and occupational factors. The
health data cover a wide spectrum: self-reported health
scales, reported prevalent and incident diseases, long-term
chronic diseases and hospitalizations, sick-leaves, handi-
caps, limitations, disabilities and injuries, healthcare uti-
lization and services provided, and causes of death. To take
into account non-participation at inclusion and attrition
throughout the longitudinal follow-up, a cohort of non-
participants was set up and will be followed through the
same national databases as participants. Inclusion begun at
the end of 2012 and more than 82,000 were already
included by September 2015. A public call for nested
research projects was launched.
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Background
Research on the causes of diseases in the field of envi-
ronmental, occupational, social, genetic or pharmacoepi-
demiology often reveals small relative risks for individual
risk factors. Very large-scale cohorts, providing high
quality phenotyping and long-term follow-up, are required
to ensure sufficient statistical power to better understand
the role of various personal and environmental factors and
their interaction with complex genetic traits. For instance,
known associations between genetic variants and chronic
diseases show typical allelic odds ratios in the range
1.1–1.4 [1]. The reliable identification of such effects
demands vast data sets [2]. Case–control studies show that
thousands of cases are required even when interest focuses
on the simplest situations, and when the research question
focuses on the study of gene-environment and gene–gene
interactions and the comprehensive exploration of causal
pathways, tens of thousands of cases will often be required.
Tens of thousands of subjects may also be required to study
a quantitative phenotype (e.g., measured blood pressure),
because allelic effect sizes may be as small as one-tenth of
a standard deviation, or even less [3]. Beginning with the
Framingham Study, which follows-up from 1948 on a few
thousand volunteers [4], much larger prospective cohorts
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including hundreds of thousands of subjects were launched
in different countries, such as the Nurses’ Health Study [5],
the One Million Women Study [6], the UK Biobank [7],
the Kadoorie Study of Chronic Disease in China [8], the
Norwegian CONOR Consortium [9], the EPIC European
Prospective Investigation into Cancer and Nutrition [10] or
LifeLines in the Netherlands [11]. Other very large popu-
lation-based cohorts with hundreds of thousands of par-
ticipants are currently being implemented in different
countries, such as the German National Cohort [12],
LifeGene in Sweden [13], or the Cartagene Cohort in
Que´bec, Canada [14].
Main objectives
The overarching objective of the CONSTANCES project is
to establish a large population-based cohort to contribute to
the development of epidemiologic research. It was
designed as a general-purpose prospective cohort intended
to serve as an open epidemiological research infrastructure
accessible to the scientific community for conducting
ancillary projects on a variety of research questions. It will
serve as an important scientific instrument, in a similar
manner to a telescope or a particle accelerator, for exam-
ple, built not to answer a specific question but rather to help
analyze a wide range of scientific problems. In this regard,
the design of CONSTANCES relied on the experience of
the GAZEL Cohort Study, an open general-purpose
prospective cohort established in 1989 by our research
group which is currently supporting more than 80 different
nested research projects on very diverse scientific topics
[15–17]. Although designed as a general-purpose cohort
intended to host nested projects with a very broad scope,
we have focused on specific areas. We are especially
interested in occupational and social factors, on chronic
diseases and aging. Regarding occupational factors,
CONSTANCES should contribute to the study of occupa-
tional exposure in the etiology of cancer and in exploring
the genetic polymorphisms that make individuals suscep-
tible to these factors [18]. Musculoskeletal disorders in
relation to working conditions and biomechanical and
psychosocial factors at work are also a key topic of interest,
focused on the short and long-term medical, social and
professional major consequences of musculoskeletal dis-
orders [19]. The effects of exposure to occupational
chemicals on chronic respiratory diseases [20] and on
neurodegenerative diseases [21] and cognitive functioning
is an important concern. Psychosocial factors at work
contribute to coronary heart disease [22], depression and
mental health [23] and other outcomes. Due to the eco-
nomic context in industrial countries, there is also a major
interest in workability and other determinants of early exit
from the labor force, as well as on determinants and con-
sequences of extending working life [24]. Social determi-
nants of health inequalities are another major area of
interest for CONSTANCES. This covers social inequalities
in the occurrence, treatment and socioeconomic conse-
quences of common conditions such as diabetes, cancer,
depression and other psychiatric problems or cardiovas-
cular diseases [25]. Aging is a major challenge in all
industrialized countries, but studies are essentially limited
to the age groups above 65 years and provide little infor-
mation about earlier life periods [26], even though factors
that lead to impairments, disabilities, and chronic diseases
at advanced ages often begin early in life, and they con-
tinue to accumulate throughout life. CONSTANCES
should contribute to the study of many research questions
about aging, such as the study of the occupational, personal
and genetic determinants of cognitive decline, the effects
of retirement on cognition, or factors that may lead to
inactivity and isolation, factors and mechanisms that con-
tribute to successful aging, and conversely those that
contribute to disabilities and/or frailty [27]. Efforts are also
to be made to understand the causes of individual and
social heterogeneity in aging by investigating the nature of
the association between risk factors and cognitive aging in
terms of cumulative risk, risk trajectories or critical period
models [28]. Research on consequences of aging is focused
on the impact of poor functional status on survival and
functioning and the potential causes of its variation by
socioeconomic position [29].
The second main objective of the CONSTANCES
cohort is to provide useful public health information to the
public health authorities and health care regulatory bodies
in order to contribute to a better knowledge of the health
and health care resource utilization of the French popula-
tion. For this purpose CONSTANCES was designed as a
large representative sample of the general French adult
population, characterized by a broad coverage of health
problems and health determinants.
Design
Cohort composition
Considering our objectives, CONSTANCES was designed
as a sample representative for age, gender and socioeco-
nomic status (SES) of the French adult population aged
18–69 at inception. However, due to our partnership with
the National Health Insurance Fund administered by the
‘‘Caisse Nationale d’Assurance Maladie des travailleurs
salaries’’ (CNAMTS), we had to restrict the source popu-
lation of CONSTANCES to salaried workers, profession-
ally active or retired and their family (more than 85 % of
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the French population, i.e. approximately 50 million peo-
ple), thus excluding agricultural and self-employed work-
ers which are affiliated to other health insurance funds.
We plan to include 200,000 participants over a 5-year
period. As CONSTANCES is a general-purpose cohort, we
assessed the potential of CONSTANCES to conduct epi-
demiologic studies likely to have good statistical power.
We estimated the number of some major health outcomes
expected in the CONSTANCES cohort over a moderately
long term in a cohort with an age and sex structure iden-
tical to that of the French general population aged
18–69 years at the last available national census. Table 1
presents the number of expected events at the end of 5, 10,
and 15 years for events for which we have reliable national
reference data [30–32]: deaths and incidence of cancer,
ischemic heart disease, and Alzheimer disease. For these
major outcomes, the number of these serious events is high
and will make possible numerous studies with satisfactory
power.
Procedures for inclusion
In France, everyone with health insurance from CNAMTS,
as well as their dependents, is entitled to receive free health
examinations that include extensive work-ups conducted in
Health Screening Centers (HSCs). Overall the 110 HSCs
located in all France conduct approximately 500,000 health
examinations annually. Thanks to our partnership with
CNAMTS, we are including the cohort participants in 22
selected HSCs located in 19 ‘‘de´partements’’ in different
regions of France (Fig. 1).
Randomly selected eligible persons (see below) receive
at home an invitation to come to their HSC. We selected
HSCs that have experience with the recruitment of large
numbers of people and with participating in epidemiolog-
ical studies. All are large, have a staff motivated to work in
epidemiology, and use advanced medical equipment; their
geographic distribution represents the principal regions of
France. We are proceeding gradually to the establishment
of the entire cohort which will last over a 5-year period.
Inception started at the end of 2012, and the final cohort
will be constituted by the end of 2017.
Those who volunteer receive questionnaires to complete
at home before attending their HSC where they sign an
informed consent and benefit for a health examination.
Procedures for longitudinal follow-up
Participants are followed-up through ‘‘active’’ procedures
(implying them directly). An annual self-administered
questionnaire is completed by the subjects at home, using
either a paper questionnaire or internet. They will also be
Table 1 Expected number of incident major health outcomes during the follow-up of the CONSTANCES cohort
5-year follow-up 10-year follow-up 15-year follow-up
Men Women Total Men Women Total Men Women Total
Death, all causes 4131 2133 6264 9727 5502 15,229 16,983 10,736 27,719
Incident cases of ischemic heart disease (35–64 years) 681 138 819 1418 290 1708 2178 452 2630
Incident cases of Alzheimer disease 265 240 505 793 1007 1800 1548 2469 4018
Incident cancers 3162 2220 5381 7036 4855 11,892 11,444 7823 19,267
Lip, oral cavity, pharynx 306 47 353 644 103 747 1005 165 1170
Colon-Rectum 357 251 608 817 590 1407 1360 1011 2370
Liver 106 16 121 232 36 268 373 60 433
Pancreas 54 34 88 121 78 199 197 133 330
Larynx 89 7 96 189 16 205 298 26 324
Lung 502 91 593 1093 199 1292 1743 321 2064
Melanoma 66 86 152 139 180 319 216 278 494
Breast 0 900 900 0 1922 1922 0 3031 3031
Uterus 0 100 100 0 220 220 0 357 357
Ovary 0 91 91 0 196 196 0 312 312
Prostate 689 0 689 1627 0 1627 2755 0 2755
Bladder 166 22 188 380 55 435 633 98 730
Kidney 113 55 168 245 123 367 390 198 589
Thyroid 19 66 85 39 134 173 58 201 259
French national reference data come from [30–32]
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invited every 5 years for a new health examination in a
HSC. Maximizing their personal participation rate is
essential. Accordingly, regular contact with participants
includes a CONSTANCES Cohort Journal, which will
present results, nested projects, etc., and is sent regularly to
participants. A website was also created (www.constances.
fr). The subjects included in CONSTANCES are also fol-
lowed up ‘‘passively’’ (so-called because this follow-up
does not require the subjects’ participation) by annual
linkage with three national social and health data
databases.
The National Retirement Insurance Fund administered
by CNAV ensures the retirement pension for every indi-
vidual in France who had health insurance from CNAMTS
at least once during his or her life. CNAV has therefore set
up a system that allows it to collect social and occupational
data from different organisms and schemes that manage
various forms of insurance and other social protection. The
CNAV regularly receives for its databases employers’
annual reports (occupation, salary), and information about
periods of employment and unemployment from social
welfare organizations (e.g., sick leave, maternity leave,
unemployment, and diverse social benefits) [33].
The National Health Insurance Fund administered by
CNAMTS manages the SNIIRAM database which covers
the entire French population [34]. The SNIIRAM contains
exhaustive individual medical detailed data from different
sources: reimbursement data (doctors and other health
professionals visits, prescribed drugs, medical devices); so-
called ‘‘long-term diseases’’ (serious chronic diseases
exempt from co-payments and user fees); hospital dis-
charge records, including for each hospitalization principal
and associated diagnoses, medical and technical proce-
dures. Table 2 shows the main data extracted from the
SNIIRAM database.
Finally, vital status and causes of death are obtained
from the National Death Registry-CepiDc [30].
Principal data collected from different sources
Here we summarize the main data to be collected from
different sources (questionnaires, medical examination,
national health and social databases), at each stage of the
study; the detailed English version of the inclusion and
follow-up data catalog can be downloaded from CON-
STANCES’ website [35, 36].
Social and demographic characteristics
Social position, educational and income level, employment
and marital status, household composition, socioeconomic
status of parents and spouse, material living conditions
Fig. 1 Geographical location of
CONSTANCES recruitment
centers in France
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(type of housing, household income, etc.), including
geocoding of the residency address.
Health
Personal and family disease history; self-reported health
scales (perceived health, quality of life, mental health, and
specific scales for cardiovascular, musculoskeletal, and
respiratory diseases); incident and prevalent diseases (from
self-reports, social security long-term diseases and hospital
discharge); sick leaves, handicaps, limitations, disabilities
and injuries and healthcare utilization and management;
and date and cause of death. In the HSC examination
weight, height, waist-hip ratio, blood pressure,
electrocardiogram, vision, hearing, and lung function,
laboratory tests (blood sugar level, lipid work-up, liver
function tests, blood creatinine levels, complete blood cell
counts, urine tests) are measured.
Behaviors
Smoking and alcohol consumption, dietary habits and
physical activity, cannabis use, sexual orientation.
Occupational factors
From questionnaires: lifelong and current occupational
exposure to chemical, physical, and biological agents;
postural, mechanical and organizational constraints; stress
at work. Full job histories are coded for linkage with
available job-exposure matrices developed by the Occu-
pational Health Department of the National Institute for
Health Surveillance [37].
Specific health problems of the elderly (45 years and older)
CONSTANCES collects detailed data on cognitive and
physical performance from the age of 45, which is earlier
in life than most of the available cohorts [38]. Neuropsy-
chologists proceed to an evaluation of functional capaci-
ties: Instrumental Activities of Daily Living (IADL) scale
[39]; cognitive functions are assessed through the MMSE
[40], trail making A–B [41, 42], Wechsler’s coding subtest
[43]; digital finger tapping test [44], word fluency, formal
lexical and semantic evocation [45, 46], RL/RI-16 memory
test [47, 48]; physical functioning assessment includes
walking speed [49], balance [50] and hand grip tests [51].
Biobank
Due to budget restrictions we plan to collect biological
samples (blood and urine) from only half of the cohort
(n = 100,000) starting in 2016 during inclusion visits to
the HSC of the new participants. For blood, we will store,
total blood, plasma aliquots on EDTA plasma separator
tube (PST), and plasma aliquots on Hep Li PST, serum
aliquots (dry serum separator tube). For urine, we will keep
aliquots. Standardized procedures for biological samples
collection will be used, including standardized blood
sampling (pre-treatment of the samples in each recruitment
center within 30 mn after the collection), transport from
each site to the central laboratory within the night (\24 h)
at 4–8 C, robotized aliquoting in cryotubes (2D barcodes)
in the central biorepository, and storage in vapor phase
nitrogen; sample retrieval will be automated. In addition to
this basic biobanking program, CONSTANCES will offer
optional programs for specific research projects on subsets
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of participants, in which additional samples such as washed
erythrocytes, RNA, proteins, mononuclear cells, saliva, or
hair and nails may be collected.
Quality control and validation of health events
The self-administered questionnaires undergo the standard
verifications: percentages of non-response, missing data,
delay in return, etc.
For standardizing data collected in the study centers, we
developed a quality program, including quality assurance
and quality control procedures in order to obtain high
quality medical examination data. We first organized
working groups composed of personal from participating
sites (MD and nurses), epidemiologists and quality assur-
ance specialists supervised by experts of each domain con-
cerned by the data measured or collected, in order to develop
standard operating procedures (SOP), which detail the
measurement method for each type of data. The SOPs also
describe the materiel admissible for the study, the required
annual certification, the periodic verifications or mainte-
nance (all SOPs can be downloaded from the CON-
STANCES website: http://www.constances.fr/espace-
scientifique/pos.php). For each measurement, all steps of the
realization were detailed in order to minimize the inter-op-
erator variation. Prior inclusion, we performed a physical
inspection of each site and each site’s employee involved in
the study has been trained prior participation. The two first
days of inclusions, a monitor was present on site to support
the study staff. Any study site representative involved in the
study has to be trained by a monitor. After training the
practice of the trainees are regularly followed by a monitor
in order to minimize drifts over time. Practices are moni-
tored on site on a monthly basis. Practice of each study site
member is followed at minimum once per year.
The quality control process includes a validation plan,
tracking the missing data, the out of ranges or any warning
waiting for predefined consistency check. Each month the
data exported from the site and imported in the CON-
STANCES database are sorted out from the database to
perform quality controls. When discrepant data are
encountered, the monitor identifies the origin of the dis-
crepancy and the concerned data have to be corrected and
reintegrated into the CONSTANCES database. For each
category of data, the monitor identifies the source docu-
ment (where the data has been recorded for the first time)
and verifies the consistency between the site data and the
CONSTANCES database extraction. Finally, we perform a
permanent statistical monitoring of the inter-operator and
inter-site variability.
As medical data extracted from the national databases
are not always accurate, particular attention is paid to
validation of the diagnoses extracted from the health-
related administrative databases, which are routinely veri-
fied using a specific procedure. Potential cases are first
identified from the available sources: self-reported diseases
in the annual follow-up questionnaire, diagnoses extracted
from the SNIIRAM database (‘‘long-term diseases’’, hos-
pital diagnoses). Participants having given a specific con-
sent for being contacted or for contacting their doctor or
hospital (97.4 % of the participants gave such a consent)
are then contacted by telephone. A short questionnaire
allows for confirming that the person really reported a
disease and for collecting additional data (date of the
occurrence of the disease for instance); the participant is
asked to send medical documents allowing for collecting
specific data and for diagnosis validation (pathology report,
electrocardiogram…). When the subject cannot be reached
or when he/she cannot provide the documents, the hospital
or the general practitioner is contacted. Finally, the cases
are adjudicated by specialized expert committees. Initially,
we are particularly focusing on some major outcomes:
cardiovascular events, cancers, and neurodegenerative
diseases.
Data management
CONSTANCES’ data are centralized in a unique database
stored in a highly secured environment. We describe here
the main features of the data management process. The first
step is sampling of the eligible people within the CNAV
database (see below); after sampling, identification data
(names, postal addresses, telephone numbers) are encryp-
ted and kept by a thrusted third party, an independent
organization in charge of sending the invitations to par-
ticipate to CONSTANCES; thus only a study number is
stored in the central CONSTANCES database. After the
inclusion of the participants in the study medical centers,
several data streams (where the participants are identified
by their study number) coming from multiple sources feed
regularly the database using different media: paper ques-
tionnaires are computerized; data from the study centers
are sent to the CONSTANCES database through internet or
by postal mail depending on their nature; data extracted
from the administrative databases are encrypted and sent to
CONSTANCES by internet by CNAMTS and CNAV;
inclusion questionnaires are completed on paper, while for
follow-up questionnaires participants can chose between
paper or internet using a specific internet platform. Consent
forms are stored by the thrusted third party. For the vali-
dation of the diagnoses, as it implies a direct contact with
the participants and/or their doctor or hospital, the thrusted
third party send the contact data (names, telephone, consent
forms) to an external telephone platform.
The CONSTANCES database itself is divided into two
parts. Raw data from the different sources are stored in a
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working database where different controls and data clean-
ing are performed and the raw data are archived. Cleaned
data are then transferred into the study database, which is
used for research. Safety is ensured by various provisions
(encryption of data, passwords, regular back-ups…).
Encrypted data are transferred to external researchers for
their studies by internet; data potentially allowing identi-
fication of the participants are impoverished (zip code
instead of address, age group instead of date of birth, etc.).
The data management system of CONSTANCES was
approved by CNIL, the national data protection authority.
Periodicity of follow-up
The periodicity of follow-up varies according to the sour-
ces. A self-administered mail questionnaire is sent annu-
ally, thus allowing close follow-up, by collecting numerous
data without asking subjects for too much work each year.
At the same time, it will facilitate rapid response for setting
up new studies and establish a sense of loyalty in the
participants; too long a delay between two questionnaires is
a factor that promotes dropping out [52]. Some data will be
collected annually (health status and reported morbidity,
life events and characteristics of place of residence,
smoking, alcohol, etc.), while others will be collected at
longer intervals, according to a planned calendar (health
scales and questionnaires for a specific health area or
specific risk factors). Because the national databases
essentially record events continuously, the follow-up of the
data they provide will be permanent. Finally, participants
will also be asked to come to the HSC every 5 years for
medical and laboratory examinations.
Control of selection effects
Selection effects are one of the major sources of bias in
epidemiologic surveys. They can bias estimates of disease
prevalence or incidence (or of prevalence of exposure to a
risk factor) and of associations between exposures and
diseases of interest. In longitudinal cohorts, selection
effects may occur at inclusion and throughout follow-up
because of cohort attrition.
The problem of biases linked to selection effects is very
different depending on whether the objectives are analytic
or descriptive [53]. In a cohort whose inclusion procedures
are the same for all subjects (the case of CONSTANCES),
in principle the exposure-disease relation does not differ
between subjects who are included and those who are not
[54–56]. Therefore, the selection procedures at inception
for CONSTANCES participants should generate minimal
bias in analytic studies, although the observed exposure
effect relationships may be affected if the highest expo-
sures are underrepresented, which often happens for factors
like alcohol or tobacco consumption. On the other hand,
the problem of attrition during follow-up may cause sub-
stantial bias if the probability of continued follow-up is
different in exposed and unexposed subjects or in those
who do or do not become ill, as it is often the case [57].
For descriptive studies of the frequency of health
problems and exposures, the parameters of interest must be
estimated in a representative sample of the target popula-
tion. In this regard, the potential concerns for CON-
STANCES are mainly incomplete geographical coverage
of the recruitment centers and factors associated with
voluntary participation. We have verified that the structure
of the population of the ‘‘de´partements’’ where the CON-
STANCES HSCs are located is essentially identical to that
for France as a whole for the principal demographic, social,
and occupational characteristics; we should thus be able to
generalize the CONSTANCES results to the French pop-
ulation (data not shown).
Using volunteer subjects inevitably produces selection
effects, even in studies that use random drawing from an
appropriate sampling base, as it is the case of CON-
STANCES, as eligible individuals may refuse participation
(become non-participants), a potential source of bias. To
compensate, researchers usually attempt to collect a mini-
mum data set for the non-participants (mainly age, sex, and
social category), to facilitate subsequent adjustments for
estimating the relevant parameters. This approach
nonetheless has some limitations. First, it is not always
possible to collect the adjustment data for non-participating
subjects. Nor is it always clear whether these data are
sufficient to control for potential bias, because we know,
for example, that within the same socioeconomic category
there are many important differences in terms of health,
behavior, lifestyles, social networks, etc. [58, 59]. Finally,
it is rarely possible to control completely for potential
selection bias because it is rare to have the relevant data
collected simultaneously for the participants and the non-
participants.
To obtain a representative sample of the target popula-
tion and to minimize the biases associated with selection
effects at inclusion and during follow-up in CON-
STANCES, we took the following steps. The sampling
base at inclusion is composed of all persons aged
18–69 years and covered by CNAMTS in the catchment
areas of the CONSTANCES HSCs. Sampling is done
within the CNAV database which includes exhaustively all
the persons in France affiliated to the CNAMTS. The
random drawing is stratified according to unequal inclusion
probabilities, based on data from participation in previous
surveys involving invitations to HSCs [60]. We also drawn
a ‘‘parallel cohort’’ from a random sample of 400,000 non-
participants for whom we prospectively collect data from
the same national databases than for the participants: social
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and occupational characteristics (sex, age, work status,
occupation, social category), through the CNAV database,
health and health-care utilization from the SNIIRAM and
the National Death Registry. Auxiliary data extracted from
CNAV and SNIIRAM cover three years before inception
for both the participants and the sample of non-participants.
We are thus able to estimate the probabilities of partici-
pation in CONSTANCES associated with sociodemo-
graphic and health variables using logistic regression
models, to compute weights for correcting unit nonre-
sponse and to estimate adjusted prevalence of question-
naire variables. As in epidemiological surveys auxiliary
health and social data are usually not available for non-
respondents, this approach has rarely been used to correct
the prevalence estimates for nonresponse bias, with few
exceptions which proved to effectively correct for nonre-
sponse [61].
A major concern of long-term prospective cohorts is
attrition, potentially inducing biases and affecting the
power of the study [52]. We can assume that almost none
of the people included in CONSTANCES will be perma-
nently lost to follow-up, since the participants will be
followed passively through the SNIIRAM, CNAV and
National Death Registry files. There will nonetheless be
attrition due to the failure to return the annual question-
naire. Coefficients of adjustment for attrition are calculated
by a method similar to the one used to calculate the
coefficient of adjustment for initial non-participation based
on the data collected at inclusion for participants as well as
the SNIIRAM and CNAV data.
Advancement
After a field pilot during a four to five-month period in
seven centers, including about 3500 subjects [62], the
recruitment started in late 2012. Currently (September
2015), more than 82,000 participants are included in the
cohort. The participation rate to the annual follow-up
questionnaire of subjects who were included in 2012, 2013
and 2014 was higher than 80 % each year.
The preliminary analysis of the available data showed
that this sample is close to the general population of adults
in France regarding the main socioeconomic variables
(Table 3).
There was quite a diverse distribution of occupations
and working conditions, lifestyle factors, and the preva-
lence rates of various diseases and symptoms were close to
those from other available French surveys (data not
shown).
We also verified that the use of auxiliary data from
national databases on both respondents and non-respon-
dents for correcting unit nonresponse and to estimate
adjusted prevalence of questionnaire variables was effi-
cient. As shown in Table 4, reweighting techniques used in
a previous work [61] proved to meaningfully improve the
estimates of prevalence in the population of different
conditions related to health and behaviors. When adjusting
only for stratification variables (age, sex and socioeco-
nomic status), changes were observed in the expected
direction reflecting the classical underrepresentation of
people with a poor health status (low self-rated health,
alcohol abstinent which are often persons having a severe
disease) or overweighed, and the over participation of ex-
smokers. We further adjusted on health data extracted from
the SNIIRAM database for both participants and non-par-
ticipants which were associated with the probability of
participation in logistic regression models (disability,
chronic diseases and hospital discharge diagnosis, number
of visits to a doctor, expenses for ambulatory care). The
changes observed with the first adjustments were markedly
amplified, yielding more accurate estimates of the preva-
lences, showing that adjusting only on ‘‘classical’’ param-
eters (age, sex and socioeconomic status) as it is sometime
done in health surveys, is not sufficient if not completely
misleading, as it is the case for persons having a fasting
plasma glucose[7 mmol: adjustment on the stratification
variables resulted in a decrease of prevalence, reflecting the
high participation of aged subjects, while adjustment on
Table 3 CONSTANCES cohort: main sociodemographic character-



















Married, civil partnerships 60.1
Divorced, separated 10.9
Widower 2.4
Data available in July 2015 (n = 57,922)
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diagnosed diabetes led on the contrary to a strong increase
of prevalence reflecting the low participation of persons
suffering from this condition.
Research in CONSTANCES
Every group in France or in other countries, public or
private, is entitled to apply to develop a nested project
within CONSTANCES and to access to its database. Pro-
jects are evaluated by the CONSTANCES Scientific
Committee on feasibility and scientific quality criteria.
A Charter describes the rules that have been established for
using the CONSTANCES infrastructure, regarding legal
aspects, data confidentiality and security, ethics, access to
the database in the case where only available data are
required or when the collection of supplementary data
directly from the cohort participants is needed, as well as
sharing of these supplementary data, access to the biolog-
ical and genetic material, responsibilities of the CON-
STANCES infrastructure and of external groups,
dissemination of data and results, publications and
authorship, acknowledgments, follow-up of the project and
funding. The material needed for applying can be down-
loaded from the CONSTANCES website (http://www.con
stances.fr/index_EN.php#propose).
A first call for proposals was launched in 2014 among a
restricted set of French investigators who collaborated in
the preparation of the protocol of CONSTANCES. More
than 40 projects covering a wide range of topics were
proposed and approved by the Scientific Committee; the
list of accepted projects is available at: http://www.con
stances.fr/espace-scientifique/projets-valides.php. In May
2015, the public call for ancillary projects proposals was
launched; it is planned that the Scientific Committee will
examine the applications twice a year.
Discussion
Considering its large size, the extensive coverage of the
French adult population, the wealth of data collected from
different sources, and its openness to the scientific com-
munity, the CONSTANCES cohort should constitute a
powerful tool for public health information and epidemi-
ologic research in many different fields.
CONSTANCES has several strengths. It was designed
both to help answer research questions in diverse areas and
to provide public health information needed by the health
authorities. To facilitate the latter aim, we devised a
specific sampling scheme including a non-participants
cohort and developed complex statistical procedures in
order to take into account selection effects at inception as
well as during the follow-up of the cohort. Once completed
CONSTANCES will be a large cohort, including persons
living and working in diverse settings, from large cities to
small villages in different regions of France, with a broad
range of socioeconomic status and trades. Numerous data
are collected at inception, including an extensive medical,
physiological and biological examination, and a large
biobank will be set up. The follow-up is extensive, relying
both on active participation of the volunteers through
annual questionnaires and regular visits to the HSCs, and
on passive methods through the regular linkage to health
and socioeconomic national exhaustive databases. Of par-
ticular importance is the high frequency of measurements
from many different sources, allowing for analyses of life
course trajectories of health in relation to personal, social,
Table 4 Crude and adjusted prevalence of selected reported conditions (percentage, 95 confidence intervals and percentage of change after
adjustment)
Crude prevalence Adjusted on stratification
variables (1)
Further adjustment on health
variables (2)




















1—Age, sex and socioeconomic status
2—Disability, chronic diseases and hospital discharge diagnosis, number of visits to a doctor, expenses for ambulatory care
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occupational factors and major life events. Specific efforts
were put into the quality of data collection and the vali-
dation of main outcomes in order to provide a highly
phenotyped cohort. A unique feature of CONSTANCES is
also to include a comprehensive set of cognitive and
physical tests starting as young as 45 years, which is earlier
in the life course than most available studies on ageing.
The CONSTANCES has also some limitations. Due to
the voluntary participation of cohort members, there will
probably be an underrepresentation of hard-to-reach sub-
jects, such as heavy drinkers or socially excluded persons.
Comparisons between participants and non-participants at
inclusion and during the follow-up through the ‘‘non-par-
ticipants cohort’’ allow assessment of potential biases due
to selection effects, but lack of sufficient numbers in some
categories might be a problem. Even more importantly,
despite its large size CONSTANCES will not offer suffi-
cient power to study rare outcomes or exposures. Simula-
tions under several hypotheses regarding the prevalence of
exposure and expected relative risk and duration of follow-
up since inception, showed that in most of the situations
where the relative risk is below 2, especially when inter-
actions have to be taken into account, power will be sat-
isfactory after at least 5 years of follow-up for situations
where the annual incidence of the outcome is over
10/100,000 and the prevalence of exposure over 10 % (data
not shown). This limit is common to all longitudinal
cohorts, which is why CONSTANCES participates in the
Biobanking and Biomolecular Resources Research Infras-
tructure-Large Prospective Cohorts (BBMRI-LPC) con-
sortium for networking of prospective studies in Europe
[63].
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